CD177 and acute lymphoblastic leukemia: To confirm CD4-specific targeting of CD4-Nb1 within the xenograft, we additionally performed ex vivo immunofluorescence of HPB-ALL tumors at 2 and 24 h post injection (Supplementary Figure S11).